Whole-organ re-engineering: A regenerative medicine approach in digestive surgery for organ replacement

Surgery Today

Volumn 43, Issue 6, 2013, Pages 587-594

  Yagi, Hiroshi ^a   Soto Gutierrez, Alejandro ^b   Kitagawa, Yuko ^a  

^a KEIO UNIVERSITY   (Japan)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Cell transplantation; Organ engineering; Organ transplantation alternatives; Stem cells; Tissue engineering

Indexed keywords

EDETIC ACID; EGTAZIC ACID;

ABDOMINAL SURGERY; BASEMENT MEMBRANE; CELL FATE; CELL POPULATION; CYTOLOGY; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; HUMAN; IMMUNOGENICITY; NONHUMAN; ORGAN DECELLULARIZATION; ORGAN TRANSPLANTATION; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION; WHOLE ORGAN REENGINEERING;

ANIMALS; BIOENGINEERING; BIOPROSTHESIS; CELL SEPARATION; DIGESTIVE SYSTEM SURGICAL PROCEDURES; EXTRACELLULAR MATRIX; HUMANS; ORGAN TRANSPLANTATION; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TISSUE THERAPY;

EID: 84878018007     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-012-0396-1     Document Type: Review

References (96)

1. Lee SG, Hwang S, Kim KH, et al. Toward 300 liver transplants a year. Surg Today. 2009;39:367-73.
2. Garg M, Jones RM, Vaughan RB, et al. Intestinal transplantation: current status and future directions. J Gastroenterol Hepatol. 2011;26:1221-8.
3. Gruessner AC, Sutherland DE, Gruessner RW. Long-term outcome after pancreas transplantation. Curr Opin Organ Transplant. 2012;17:100-5.
4. Fung YC, Sobin SS. Elasticity of the pulmonary alveolar sheet. Circ Res. 1972;30:451-69.
5. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920-6.
6. Meezan E, Hjelle JT, Brendel K, et al. A simple, versatile, nondisruptive method for the isolation of morphologically and chemically pure basement membranes from several tissues. Life Sci. 1975;17:1721-32.
7. Rojkind M, Gatmaitan Z, Mackensen S, et al. Connective tissue biomatrix: its isolation and utilization for long-term cultures of normal rat hepatocytes. J Cell Biol. 1980;87:255-63.
8. Bissell MJ, Hall HG, Parry G. How does the extracellular matrix direct gene expression? J Theor Biol. 1982;99:31-68.
9. Lwebuga-Mukasa JS, Ingbar DH, Madri JA. Repopulation of a human alveolar matrix by adult rat type II pneumocytes in vitro. A novel system for type II pneumocyte culture. Exp Cell Res. 1986;162:423-35.
10. Kim SS, Kaihara S, Benvenuto MS, et al. Regenerative signals for intestinal epithelial organoid units transplanted on biodegradable polymer scaffolds for tissue engineering of small intestine. Transplantation. 1999;67:227-33.
11. Nakase Y, Hagiwara A, Nakamura T, et al. Tissue engineering of small intestinal tissue using collagen sponge scaffolds seeded with smooth muscle cells. Tissue Eng. 2006;12:403-12.
12. Javaid Ur R, Waseem T. Intestinal tissue engineering: where do we stand? Surg Today. 2008;38:484-6.
13. Demetriou AA, Whiting JF, Feldman D, et al. Replacement of liver function in rats by transplantation of microcarrier-attached hepatocytes. Science. 1986;233:1190-2.
14. Rozga J, Williams F, Ro MS, et al. Development of a bioartificial liver: properties and function of a hollow-fiber module inoculated with liver cells. Hepatology. 1993;17:258-65.
15. Stutchfield BM, Simpson K, Wigmore SJ. Systematic review and meta-analysis of survival following extracorporeal liver support. Br J Surg. 2011;98:623-31.
16. Reach G, Jaffrin MY, Desjeux JF. A U-shaped bioartificial pancreas with rapid glucose-insulin kinetics. In vitro evaluation and kinetic modelling. Diabetes. 1984;33:752-61.
17. Lombardi CP, Urso A, Catapano G, et al. Membrane bioreactors as hybrid artificial pancreas: experimental evaluation. Int J Artif Organs. 1992;15:126-30.
18. Park JK, Lee DH. Bioartificial liver systems: current status and future perspective. J Biosci Bioeng. 2005;99:311-9.
19. Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459:262-5.
20. Spence JR, Mayhew CN, Rankin SA, et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature. 2011;470:105-9.
21. Hay DC, Fletcher J, Payne C, et al. Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc Natl Acad Sci USA. 2008;105:12301-6.
22. Basma H, Soto-Gutierrez A, Yannam GR, et al. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology. 2009;136:990-9.
23. Si-Tayeb K, Noto FK, Nagaoka M, et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology. 2010;51:297-305.
24. Kajiwara M, Aoi T, Okita K, et al. Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci USA. 2012;109:12538-43.
25. Woo DH, Kim SK, Lim HJ, et al. Direct and indirect contribution of human embryonic stem cell-derived hepatocyte-like cells to liver repair in mice. Gastroenterology. 2012;142:602-11.
26. Chen YF, Tseng CY, Wang HW, et al. Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol. Hepatology. 2012;55:1193-203.
27. Bonner-Weir S, Weir GC. New sources of pancreatic beta-cells. Nat Biotechnol. 2005;23:857-61.
28. D'Amour KA, Bang AG, Eliazer S, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol. 2006;24:1392-401.
29. Kroon E, Martinson LA, Kadoya K, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol. 2008;26:443-52.
30. Discher DE, Mooney DJ, Zandstra PW. Growth factors, matrices, and forces combine and control stem cells. Science. 2009;324:1673-7.
31. Cheng HW, Tsui YK, Cheung KM, et al. Decellularization of chondrocyte-encapsulated collagen microspheres: a three-dimensional model to study the effects of acellular matrix on stem cell fate. Tissue Eng Part C Methods. 2009;15:697-706.
32. Barkan D, Green JE, Chambers AF. Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer. 2010;46:1181-8.
33. Badylak SF. The extracellular matrix as a biologic scaffold material. Biomaterials. 2007;28:3587-93.
34. Ott HC, Matthiesen TS, Goh SK, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med. 2008;14:213-21.
35. Wainwright JM, Czajka CA, Patel UB, et al. Preparation of cardiac extracellular matrix from an intact porcine heart. Tissue Eng Part C Methods. 2010;16:525-32.
36. Uygun BE, Soto-Gutierrez A, Yagi H, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med. 2010;16:814-20.
37. Baptista PM, Siddiqui MM, Lozier G, et al. The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology. 2011;53:604-17.
38. Ott HC, Clippinger B, Conrad C, et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med. 2010;16:927-33.
39. Price AP, England KA, Matson AM, et al. Development of a decellularized lung bioreactor system for bioengineering the lung: the matrix reloaded. Tissue Eng Part A. 2010;16:2581-91.
40. Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. Biomaterials. 2011;32:3233-43.
41. Wells RG. The role of matrix stiffness in regulating cell behavior. Hepatology. 2008;47:1394-400.
42. Rozario T, DeSimone DW. The extracellular matrix in development and morphogenesis: a dynamic view. Dev Biol. 2010;341:126-40.
43. Bissell MJ, Aggeler J. Dynamic reciprocity: how do extracellular matrix and hormones direct gene expression? Prog Clin Biol Res. 1987;249:251-62.
44. Nelson CM, Bissell MJ. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol. 2006;22:287-309.
45. Cartmell JS, Dunn MG. Effect of chemical treatments on tendon cellularity and mechanical properties. J Biomed Mater Res. 2000;49:134-40.
46. Yang B, Zhang Y, Zhou L, et al. Development of a porcine bladder acellular matrix with well-preserved extracellular bioactive factors for tissue engineering. Tissue Eng Part C Methods. 2010;16:1201-11.
47. Flynn LE. The use of decellularized adipose tissue to provide an inductive microenvironment for the adipogenic differentiation of human adipose-derived stem cells. Biomaterials. 2010;31:4715-24.
48. Cortiella J, Niles J, Cantu A, et al. Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. Tissue Eng Part A. 2010;16:2565-80.
49. Gui L, Chan SA, Breuer CK, et al. Novel utilization of serum in tissue decellularization. Tissue Eng Part C Methods. 2010;16:173-84.
50. Remlinger NT, Czajka CA, Juhas ME, et al. Hydrated xenogeneic decellularized tracheal matrix as a scaffold for tracheal reconstruction. Biomaterials. 2010;31:3520-6.
51. Hashimoto Y, Funamoto S, Sasaki S, et al. Preparation and characterization of decellularized cornea using high-hydrostatic pressurization for corneal tissue engineering. Biomaterials. 2010;31:3941-8.
52. Phillips M, Maor E, Rubinsky B. Nonthermal irreversible electroporation for tissue decellularization. J Biomech Eng. 2010;132:091003.
53. Fox IJ, Chowdhury JR, Kaufman SS, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med. 1998;338:1422-6.
54. Toole BP. Hyaluronan in morphogenesis. Semin Cell Dev Biol. 2001;12:79-87.
55. Matrosova VY, Orlovskaya IA, Serobyan N, et al. Hyaluronic acid facilitates the recovery of hematopoiesis following 5-fluorouracil administration. Stem cells. 2004;22:544-55.
56. Arnaoutova I, George J, Kleinman HK, et al. Basement membrane matrix (BME) has multiple uses with stem cells. Stem cell Rev. 2012;8:163-9.
57. Guhr A, Kurtz A, Friedgen K, et al. Current state of human embryonic stem cell research: an overview of cell lines and their use in experimental work. Stem cells. 2006;24:2187-91.
58. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-76.
59. Pournasr B, Khaloughi K, Salekdeh GH, et al. Concise review: alchemy of biology: generating desired cell types from abundant and accessible cells. Stem cells. 2011;29:1933-41.
60. Sneddon JB, Borowiak M, Melton DA. Self-renewal of embryonic-stem-cell- derived progenitors by organ-matched mesenchyme. Nature 2012 [Epub ahead of print].
61. Coulombel L, Vuillet MH, Leroy C, et al. Lineage- and stage-specific adhesion of human hematopoietic progenitor cells to extracellular matrices from marrow fibroblasts. Blood. 1988;71:329-34.
62. Macchiarini P, Jungebluth P, Go T, et al. Clinical transplantation of a tissue-engineered airway. Lancet. 2008;372:2023-30.
63. Adewumi O, Aflatoonian B, Ahrlund-Richter L, et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol. 2007;25:803-16.
64. Wu SM, Hochedlinger K. Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol. 2011;13:497-505.
65. Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer. 2011;11:268-77.
66. Ilic D, Polak J. Stem cell based therapy-where are we going? Lancet. 2012;379:877-8.
67. Allaire E, Guettier C, Bruneval P, et al. Cell-free arterial grafts: morphologic characteristics of aortic isografts, allografts, and xenografts in rats. J Vasc Surg. 1994;19:446-56.
68. Allaire E, Bruneval P, Mandet C, et al. The immunogenicity of the extracellular matrix in arterial xenografts. Surgery. 1997;122:73-81.
69. Hawkins JA, Hillman ND, Lambert LM, et al. Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts. J Thorac Cardiovasc Surg. 2003;126:247-52. discussion 252-3.
70. Madden R, Lipkowitz G, Benedetto B, et al. Decellularized cadaver vein allografts used for hemodialysis access do not cause allosensitization or preclude kidney transplantation. Am J Kidney Dis Off J Natl Kidney Found. 2002;40:1240-3.
71. Reagan BJ, Madden MR, Huo J, et al. Analysis of cellular and decellular allogeneic dermal grafts for the treatment of full-thickness wounds in a porcine model. J Trauma. 1997;43:458-66.
72. Barret JP, Dziewulski P, McCauley RL, et al. Dural reconstruction of a class IV calvarial burn with decellularized human dermis. Burns J Int Soc Burn Inj. 1999;25:459-62.
73. Albo D, Awad SS, Berger DH, et al. Decellularized human cadaveric dermis provides a safe alternative for primary inguinal hernia repair in contaminated surgical fields. Am J Surg. 2006;192:e12-7.
74. Butler CE, Prieto VG. Reduction of adhesions with composite AlloDerm/polypropylene mesh implants for abdominal wall reconstruction. Plast Reconstr Surg. 2004;114:464-73.
75. Butler CE, Langstein HN, Kronowitz SJ. Pelvic, abdominal, and chest wall reconstruction with AlloDerm in patients at increased risk for mesh-related complications. Plastic Reconstr Surg. 2005;116:1263-75. discussion 1276-7.
76. Keane TJ, Londono R, Turner NJ, et al. Consequences of ineffective decellularization of biologic scaffolds on the host response. Biomaterials. 2012;33:1771-81.
77. Kaushal S, Amiel GE, Guleserian KJ, et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med. 2001;7:1035-40.
78. Liu Y, Bharadwaj S, Lee SJ, et al. Optimization of a natural collagen scaffold to aid cell-matrix penetration for urologic tissue engineering. Biomaterials. 2009;30:3865-73.
79. Simon P, Kasimir MT, Seebacher G, et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2003;23:1002-6. discussion 1006.
80. Schreiber C, Eicken A, Seidl S, et al. Unexpected early failure of a decellularized right ventricle to pulmonary artery graft. Ann Thorac Surg. 2008;86:2026-7. author reply 2027-8.
81. Isch JA, Engum SA, Ruble CA, et al. Patch esophagoplasty using AlloDerm as a tissue scaffold. J Pediatr Surg. 2001;36:266-8.
82. White JK, Agnihotri AK, Titus JS, et al. A stentless trileaflet valve from a sheet of decellularized porcine small intestinal submucosa. Ann Thorac Surg. 2005;80:704-7.
83. Gabouev AI, Schultheiss D, Mertsching H, et al. In vitro construction of urinary bladder wall using porcine primary cells reseeded on acellularized bladder matrix and small intestinal submucosa. Int J Artif Organs. 2003;26:935-42.
84. Badylak SF, Vorp DA, Spievack AR, et al. Esophageal reconstruction with ECM and muscle tissue in a dog model. J Surg Res. 2005;128:87-97.
85. Mertsching H, Schanz J, Steger V, et al. Generation and transplantation of an autologous vascularized bioartificial human tissue. Transplantation. 2009;88:203-10.
86. Lin P, Chan WC, Badylak SF, et al. Assessing porcine liver-derived biomatrix for hepatic tissue engineering. Tissue Eng. 2004;10:1046-53.
87. Linke K, Schanz J, Hansmann J, et al. Engineered liver-like tissue on a capillarized matrix for applied research. Tissue Eng. 2007;13:2699-707.
88. Nahmias Y, Schwartz RE, Hu WS, et al. Endothelium-mediated hepatocyte recruitment in the establishment of liver-like tissue in vitro. Tissue Eng. 2006;12:1627-38.
89. Mitaka T, Sato F, Mizuguchi T, et al. Reconstruction of hepatic organoid by rat small hepatocytes and hepatic nonparenchymal cells. Hepatology. 1999;29:111-25.
90. Michalopoulos GK, Bowen WC, Zajac VF, et al. Morphogenetic events in mixed cultures of rat hepatocytes and nonparenchymal cells maintained in biological matrices in the presence of hepatocyte growth factor and epidermal growth factor. Hepatology. 1999;29:90-100.
91. Harada K, Mitaka T, Miyamoto S, et al. Rapid formation of hepatic organoid in collagen sponge by rat small hepatocytes and hepatic nonparenchymal cells. J Hepatol. 2003;39:716-23.
92. Soto-Gutierrez A, Navarro-Alvarez N, Yagi H, et al. Engineering of an hepatic organoid to develop liver assist devices. Cell Transplant. 2010;19:815-22.
93. Floden EW, Malak SF, Basil-Jones MM, et al. Biophysical characterization of ovine forestomach extracellular matrix biomaterials. J Biomed Mater Res B Appl Biomater. 2011;96:67-75.
94. Soto-Gutierrez A, Zhang L, Medberry C, et al. A whole-organ regenerative medicine approach for liver replacement. Tissue Eng Part C Methods. 2011;17:677-86.
95. Baptista PM, Siddiqui MM, Lozier G, et al. The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology 2011;53(2):604-17.
96. Sancho-Bru P, Najimi M, Caruso M, et al. Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside? Gut. 2009;58:594-603.